AJP - Heart Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 266: H1386-H1394, 1994;
0363-6135/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rose, C. P.
Right arrow Articles by De Champlain, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rose, C. P.
Right arrow Articles by De Champlain, J.

AJP - Heart and Circulatory Physiology, Vol 266, Issue 4 1386-H1394, Copyright © 1994 by American Physiological Society

ARTICLES

Constitutive nonexocytotic norepinephrine release in sympathetic curves of in situ canine heart

C. P. Rose, D. Cousineau, C. A. Goresky and J. De Champlain
McGill University Medical Clinic, Montreal General Hospital, Department of Medicine, Quebec, Canada.

Nonexocytotic norepinephrine bulk overflow from sympathetic nerves has been previously demonstrated in the perfused isolated heart only after inhibition of sympathetic nerve metabolism by hypoxia, ischemia, or metabolic inhibitors. The measurement, however, ignores simultaneous uptake of norepinephrine by sympathetic nerves. We quantitated simultaneous norepinephrine uptake and release in pentobarbital-anesthetized dogs by the use of a transient tracer approach, the multiple indicator dilution technique, combined with measurement of endogenous arterial and venous plasma norepinephrine levels. Sympathetic vesicles were previously depleted by reserpine, and desipramine was used to inhibit the neuronal membrane pump. Labeled albumin, sucrose, and norepinephrine were injected into the coronary artery, and sequential samples were collected from the coronary sinus. Reserpine pretreatment significantly depleted tissue and decreased plasma norepinephrine levels; tracer norepinephrine uptake increased slightly, and there was a substantial decrease in the rate of release of unlabeled norepinephrine. Desipramine then decreased tracer uptake and virtually eliminated norepinephrine release. We conclude that desipramine-suppressible, constitutive nonexocytotic norepinephrine release is present in cardiac sympathetic nerves.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
T. Kawada, T. Yamazaki, T. Akiyama, M. Inagaki, T. Shishido, C. Zheng, Y. Yanagiya, M. Sugimachi, and K. Sunagawa
Vagosympathetic interactions in ischemia-induced myocardial norepinephrine and acetylcholine release
Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H216 - H221.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
D. S. Goldstein, C. Holmes, R. O. Cannon, G. Eisenhofer, and I. J. Kopin
Sympathetic Cardioneuropathy in Dysautonomias
N. Engl. J. Med., March 6, 1997; 336(10): 696 - 702.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online